Oric Pharmaceuticals
ORIC
12.01
+0.03
+0.25%
Oric Pharmaceuticals
US · ORIC
#3089 by market cap
Listed 2020
12.01
+0.03
+0.25%
Live - 5344 symbols - heartbeat 129s ago
· 2026-10-08 07:00
Pre-market
11.51
-4.16%
After-hours
12.01
0.00%
- Market cap
- 1.24B
- P/E (TTM)i
- -9.24
- P/Bi
- 3.27
- EPSi
- -1.47
- Div yieldi
- 0.00%
- 52W posi
- 64%
Reader sentiment
Are you bullish or bearish on ORIC?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 9 analysts
Buy
Avg price target
22.78 +89.7%
Price target rangecurrent 12.01
Low14.00
Avg22.78
High27.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-23 | BTIG | -- | BUY | 26.00 |
| 2026-08-10 | H.C. Wainwright | -- | BUY | 27.00 |
| 2026-08-06 | J.P. Morgan | -- | BUY | 23.00 |
| 2026-08-04 | Wells Fargo | -- | BUY | 25.00 |
| 2026-08-04 | JonesTrading | -- | BUY | 25.00 |
| 2026-08-04 | Piper Sandler | -- | BUY | 22.00 |
| 2026-08-04 | Evercore | -- | BUY | 25.00 |
| 2026-08-04 | Stifel | -- | BUY | 14.00 |
| 2026-08-03 | Guggenheim | -- | BUY | 18.00 |
| 2026-06-29 | Piper Sandler | -- | BUY | 22.00 |
| 2026-06-24 | H.C. Wainwright | -- | BUY | 25.00 |
| 2026-06-12 | Stifel | -- | BUY | 14.00 |
| 2026-06-11 | Wells Fargo | -- | BUY | 25.00 |
| 2026-06-11 | Stifel | -- | BUY | 14.00 |
| 2026-06-08 | H.C. Wainwright | -- | BUY | 25.00 |
| 2026-06-02 | Goldman Sachs | -- | BUY | 15.00 |
| 2026-05-15 | Goldman Sachs | -- | BUY | -- |
| 2026-05-05 | Wells Fargo | -- | BUY | 25.00 |
| 2026-05-05 | JonesTrading | -- | BUY | 25.00 |
| 2026-05-05 | Piper Sandler | -- | BUY | 22.00 |
| 2026-05-05 | Citi | -- | BUY | 16.00 |
| 2026-05-05 | H.C. Wainwright | -- | BUY | 25.00 |
| 2026-05-04 | Guggenheim | -- | BUY | 18.00 |
| 2026-04-13 | J.P. Morgan | -- | BUY | -- |
| 2026-04-02 | H.C. Wainwright | -- | BUY | 25.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Actual move |
|---|---|---|---|
| 2021/Q4 | 2022-03-21 | After close | -28.74% |
| 2020/Q2 | 2020-08-05 | After close | +14.07% |
Quote time 2026-10-08 07:00:26 · For reference only, not investment advice and not tailored to your situation.